IVD Test Reagent/Kits, Immunoassay, Autoimmune, Connective Tissue, SS-B/La Antibody

Definition : Immunoassay reagents intended to perform qualitative and/or quantitative analyses on a body fluid sample (e.g., serum) to determine antibodies (termed SS-B or SS-B/La) to an RNA/protein complex (an extractable nuclear antigen). Circulating SS-B antibodies are present in autoimmune connective-tissue diseases, particularly in Sjogren's syndrome which is characterized by keratoconjunctivitis and xerostomia.

Entry Terms : "SS-B Antibody Determination Reagents" , "Sjogren's Syndrome Antibody (type SSB/La) Determination Reagents" , "La Antigen Antibody Determination Reagents" , "La Antibody Determination Reagents" , "Reagents, Immunoassay, Autoimmune, Connective Tissue, SS-B/La Antibody"

UMDC code : 20083

Filters
Manufacturers
Distributors
U.S.companies only
Suppress Subsidiary Companies
   

1-5 of 5 Match(es).

Calbiotech Inc

Company Type: Parent

Calbiotech specialty is in custom design of immunoassay products for human and animal applications.

Hemagen Diagnostics Inc

Company Type: Parent

Hemagen Inc. was founded in 1985 by a group of scientists from the Boston University School of Medicine.

Mayo Medical Laboratories

Company Type: Parent

TheraTest Laboratories Inc

Company Type: Parent

TheraTest Laboratories, Inc.™ was founded in 1988 by a group of eminent clinical rheumatologists and laboratory investigators from the University of Illinois at Chicago. They realized the need to develop accurate, sensitive and reproducible methods of detecting and measuring autoantibodies in their patients.

Zeus Scientific Inc

Company Type: Parent

ZEUS Scientific is a privately held corporation that was founded in 1976. The company began producing IFA (immunofluorescence assay) test systems followed ELISA and now multiplex (AtheNA Multi-Lyte) immunoassays. New products are developed to expand the menu which allows laboratories to run an increasing number of assays with common protocols and common reagents, as well as developing new tests to more accurately diagnose patients. In 1987 ZEUS Scientific was the first company to develop, receive appropriate regulatory clearance and bring to market a serological assay to test for Lyme disease – a condition with high prevalence in the local community where ZEUS Scientific is located.

1-5 of 5 Match(es).

 

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs
Medical Product Guide Cancer Therapy Advisor Product Zone